Shade Moody
Neurology with Special Qualifications in Child Neurology · Houston, TXNPI 1285844514
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $134,966 of the $193,903 with a category attached, or 69.6%. 17 manufacturers reported payments, led by Genentech USA, Inc. at 53.3% of the total. Among neurology with special qualifications in child neurology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 300 payments — averaging $646.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$103K
- Biogen$69K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$14K
- Genentech, Inc.$7K
- Sanofi$204
- Abbott$122
- plus $347 from 11 others
Across 3 payments — averaging $22,070 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$66K
What the payments were for
- Consulting fees$26,17814%
- Speaking & faculty fees$134,96670%
- Travel & lodging$28,00014%
- Food & beverage$4,5522%
- Education$2070%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 131 | $103,269 |
| Biogen | 120 | $69,029 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 22 | $14,163 |
| Genentech, Inc. | 9 | $6,769 |
| Sanofi | 5 | $204 |
| Abbott | 1 | $122 |
| Janssen Scientific Affairs, LLC | 1 | $121 |
| Catalyst Pharmaceuticals, Inc. | 1 | $33 |
| Philips North America LLC | 2 | $28 |
| NS Pharma, Inc. | 1 | $27 |
| UCB, Inc. | 1 | $26 |
| Baxter Healthcare | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| ITF Therapeutics LLC | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Novartis | 1 | $16 |
| CSL Behring | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$193,903 in reported general payments places this provider in the 95th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
See all neurology with special qualifications in child neurology providers in Texas →
Other neurology with special qualifications in child neurology in Houston
- Huda ZoghbiHouston$5.5M
- Mary Kay KoenigHouston$171K
- Gretchen von AllmenHouston$31K
- Victoria HardwickHouston$10K
- Joshua RotenbergHouston$9K
- Mered ParnesHouston$5K
- Sarah WilsonHouston$5K
- Roy EltermanDallas$5.9M
- Diana CastroDenton$343K
- Michael PerryFort Worth$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.